Assessment of the Efficacy and Safety of a DYnaMic Peripheral DegradatiON Myopia Disorder Control in Myopic Children ״DYMOND Study״
- Sponsor
- NovaSight
- Study ID
- NCT07390500
- Phase
- PHASE2
- Status
- Recruiting
Conditions
- Myopia
Eligibility Criteria
- Sex
- ALL
- Age
- 6 Years - 12 Years
- Healthy Volunteers
- Not accepted
Interventions
- TrackSight — DEVICEapplying a predefined combination of peripheral chromatic blur and contrast reduction during normal screen use
Study Details
The DYMOND study evaluates the safety and effectiveness of TrackSight™, a digital medical application designed to slow myopia (nearsightedness) progression in children during everyday screen use. TrackSight uses eye-tracking technology to keep central vision clear while subtly adjusting the image in the peripheral viewing area, based on established scientific principles known to influence eye growth. Up to 150 children aged 6 to 12 with myopia will participate at sites in Israel and Hong Kong. All participants will continue wearing their regular single-vision glasses and will be randomly assigned to use TrackSight with or without active visual adjustment for 12 months. Eye examinations and safety assessments will be conducted at the start of the study and after 6 and 12 months. The study aims to determine whether this non-invasive digital approach can safely slow myopia progression in children.
Key Dates
- First listed
- Feb 5, 2026
- Start date
- Dec 24, 2025
- Status verified
- Jan 2026
- Primary completion
- Jun 30, 2027
- Completion
- Aug 31, 2027
Study Design
- Enrollment
- 150 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: TrackSight™ with active peripheral image degradation (blur)Participants use TrackSight™ with active peripheral image degradation enabled using combination #1 during their normal screen activities. Central vision remains clear while the peripheral image is digitally modified. Standard single-vision glasses are worn at all times.
- Experimental: rackSight™ with active peripheral image degradation (contrast)Participants use TrackSight™ with active peripheral image degradation enabled using combination #2, which applies a different level or pattern of visual modification during screen use. Central vision is unaffected, and standard single-vision glasses are worn throughout the study.
- Sham Comparator: TrackSight™ with the peripheral image degradation function disabled (control).Participants use the same TrackSight™ software and device, but the peripheral image degradation feature is disabled. Screen use and standard single-vision glasses remain unchanged, serving as the control condition.
Primary Outcome Measure
change in axial length [ Time Frame: 12 months ]
Central Contacts
- Oren Yehezkel, PhD972544552568
Related Studies
- Diagnostic Innovations in Glaucoma StudyRecruiting · University of California, San Diego · La Jolla, California
- Clinical Applications of Advanced Ophthalmic ImagingRecruiting · University of Miami · Miami, Florida
- Contoura With Phorcides Compared to Wavefront Optimized LASIKRecruiting · Daniel Terveen · Bozeman, Montana
- Axial Length With Adult Onset Myopia (ALWAOM)Enrolling By Invitation · Art Optical Contact Lens, Inc. · St Louis, Missouri